Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto - 6-MTH group results

Nov 10 (Reuters)-  
             Rohto Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   6 months ended      6 months ended       Year to  
                  Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               78.50               71.30           165.00     
                   (+10.1 pct)         (-7.8 pct)       (+6.7 pct)   
  Operating            8.66                6.47            16.80     
                   (+33.9 pct)         (-9.9 pct)       (+8.7 pct)   
  Recurring            8.75                6.82            16.90     
                   (+28.3 pct)         (-9.1 pct)       (+5.9 pct)   
  Net                  5.65                4.19            10.50     
                   (+34.8 pct)         (-14.0 pct)      (+4.9 pct)   
  EPS               49.58 yen           36.83 yen        92.17 yen   
  EPS Diluted       49.37 yen           36.68 yen                    
  Ann Div                               21.00 yen        22.00 yen   
  -Q2 div           11.00 yen           10.00 yen                    
  -Q4 div                               11.00 yen        11.00 yen   
   
  NOTE - Rohto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Rohto Pharmaceutical

See all news